Nexalin Technology, Inc.
NXL Nasdaq· Electromedical & Electrotherapeutic Apparatus
Last close · Oct 26, 2026
$1.71
KIRA · Stoqly’s AI analyst, in plain words
- Nexalin Technology, Inc. had $0.3M of revenue in fiscal 2025, up 78.8% on the year before.
- Its operating margin was −2,782.1%, up 1,814.6 pts: of every 100 in sales, about −2,782 is left after running the business.
- Nexalin Technology, Inc. lost $8.2M in fiscal 2025.
Market cap
$36.2M
P/E
—
Revenue
$0.3M
Net income
−$8.2M
Free cash flow
—
Operating margin
−2,782.1%
Nexalin Technology, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+78.8%
Yes. Sales grew 78.8% last year.
Does it make a profit?
−2,726.2%
No. It lost money last year.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Nexalin Technology, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 25, 2026
- Legal name
- Nexalin Technology, Inc.
- CIK
- 0001527352
Nexalin Technology, Inc. · NXL
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.1M | $1.3M | $0.1M | $0.2M | $0.3M |
| Revenue growth | — | 817.0% | −91.6% | 52.4% | 78.8% |
| Net interest income | — | — | $0.0M | −$0.0M | −$0.0M |
| Gross margin | 85.1% | 72.5% | 76.9% | 78.3% | 79.7% |
| Operating margin | −4,176.7% | −138.7% | −5,145.7% | −4,596.7% | −2,782.1% |
| Net income | −$6.1M | −$1.7M | −$4.6M | −$7.6M | −$8.2M |
| Net margin | −4,217.9% | −128.5% | −4,199.4% | −4,509.3% | −2,726.2% |
| Diluted EPS | — | −$0.30 | −$0.63 | −$0.83 | −$0.50 |
| Cash | |||||
| Cash from operations | −$1.1M | −$2.2M | −$3.8M | −$3.9M | −$5.0M |
| Share count change | — | — | 32.0% | 25.3% | 77.9% |
| Debt and strength | |||||
| Cash and short-term investments | $0.7M | $7.0M | $2.9M | $3.5M | $3.7M |
| Shareholders' equity | −$1.7M | $5.5M | $3.2M | $3.7M | $3.7M |
| Current ratio | 0.3x | 3.8x | 8.1x | 7.2x | 4.8x |
| Interest coverage | −73.1x | −30.9x | −146.8x | — | — |
| Returns and quality | |||||
| Return on equity | — | −89.4% | −107.0% | −221.1% | −221.5% |
| Return on tangible equity | — | −31.0% | −149.9% | −222.7% | −241.0% |
| Piotroski F-score | — | 2 | 3 | 3 | 4 |
| Altman Z'' | −374.2 | −25.6 | −66.3 | −65.3 | −68.2 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Nexalin Technology, Inc. · NXL
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.71 a share, the company is worth $36.2M.
Source: SEC EDGAR XBRL filings (CIK 0001527352). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.